NCT06819280View on ClinicalTrials.gov

Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients with Advanced Colorectal Cancer

NARecruitingINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

June 28, 2024

Primary Completion Date

May 27, 2027

Study Completion Date

May 27, 2027

Conditions

Adult

Interventions

BIOLOGICAL

GT307 injection

GT307 injection to treat Advanced Colorectal Cancer

Trial Locations (1)

Unknown

RECRUITING

Shanghai Jiaotong University School of Medcine, Renji Hospital, Shanghai

Sponsors

Lead Sponsor

Grit Biotechnology

All Listed Sponsors

lead

Grit Biotechnology

INDUSTRY

NCT06819280 - Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients with Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter